FEG
CELG

Financial Enhancement Group’s Celgene Corp CELG Stock Holding History

Financial Enhancement Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$5K – 315
2019
Q3 		$5K Hold
50
– – ﹤0.01% 224
2019
Q2 		$5K Sell
50
-200
-80% -$19K ﹤0.01% 223
2019
Q1 		$24K Buy
250
+200
+400% +$17.5K 0.01% 171
2018
Q4 		$4K Hold
50
– – ﹤0.01% 217
2018
Q3 		$4K Hold
50
– – ﹤0.01% 217
2018
Q2 		$4K Hold
50
– – ﹤0.01% 217
2018
Q1 		$4K Buy
+50
New +$4.8K ﹤0.01% 221

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Financial Enhancement Group's CELG Position: Q4 2019 in Review

Financial Enhancement Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 50 shares — an estimated $5K sold.

Financial Enhancement Group first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $24K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Financial Enhancement Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Financial Enhancement Group sold 50 Celgene Corp shares in Q4 2019, an estimated $5K.
  • Financial Enhancement Group first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Financial Enhancement Group's Celgene Corp position peaked at $24K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Financial Enhancement Group's 13F filing for Q4 2019, filed 31 Jan 2020.